ArticleBMJ oncology2024

First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours.

Aung Naing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.